| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.1M | — | -2.0% |
| Cost of Revenue | $4.0M | — | -22.4% |
| Gross Profit | $18.0M | — | +4.1% |
| R&D Expense | $7.2M | — | -3.4% |
| SG&A Expense | $4.8M | — | -67.8% |
| Operating Income | -$5.6M | — | -8.2% |
| Income Tax | $0 | — | — |
| Net Income | -$6.7M | — | -1.5% |
| EPS (Basic) | -$0.20 | — | +4.8% |
| EPS (Diluted) | -$0.20 | — | +4.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.8M | -31.9% | -45.3% |
| Short-term Investments | $39.2M | -0.4% | -0.1% |
| Accounts Receivable | $14.8M | +0.7% | -4.2% |
| Inventory | $16.7M | -1.2% | +22.9% |
| Current Assets | $87.0M | -7.5% | -10.8% |
| Total Assets | $98.9M | -6.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.9M | — | +21.1% |
| Capital Expenditures | $117K | — | +216.2% |
| Investing Cash Flow | -$117K | — | -216.2% |
| Financing Cash Flow | -$166K | — | -100.8% |
| Free Cash Flow | -$6.0M | — | +20.0% |
| -10.3% |
| Current Liabilities | $16.2M | -9.2% | +9.9% |
| Long-term Debt | $59.0M | +0.2% | -1.3% |
| Total Liabilities | $84.4M | -2.4% | -1.7% |
| Stockholders' Equity | $14.5M | -24.1% | -40.4% |